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Introduction 62
Release of virus particles from infected cells is the last essential step of the viral replication 63 cycle. In the course of this process, virions face the challenging task of crossing the cell envelope. 64
Membrane remodelling by PVAP 166
In silico secondary structure predictions (14) and hydrophobicity analysis (15) of PVAP suggest 167 that the protein consists of an N-terminal transmembrane helix (residues 5-34), followed by 168 three hydrophilic α-helices of two to three turns each, separated by short linker regions 169 ( Supplementary Fig. 2 ). The PSORT-server (16) indicated that PVAP does not contain a pre-170 sequence. This is consistent with a previous study of the N-terminal amino acid sequence of 171 purified PVAP of SIRV2 with Edman degradation, which did not indicate a cleavable signal 172 sequence (9) . Thus, we assumed that the hydrophobicity of its predicted N-terminal 173 transmembrane segment drives the spontaneous insertion of PVAP into the lipid bilayer. To test 174 this hypothesis, PVAP was expressed in the Saccharomyces cerevisiae, an eukaryotic organism. 175
Cells were harvested 16 hours after induction of PVAP expression, high-pressure frozen and 176 freeze-substituted. In addition, sections prepared by the Tokuyasu method (17) were 177 immunolabeled with antibodies raised against PVAP. All samples were analysed by transmission 178 electron microscopy. Surprisingly, VAPs were found in most, if not all, cellular membranes. In 179 terms of size and appearance, the pyramids were indistinguishable from those that assembled in 180
E.coli after PVAP expression or in S. islandicus after SIRV2 infection. PVAP-specific antibodies 181
labeled VAPs in the nuclear envelope, the endoplasmic reticulum, Golgi apparatus, intracellular 182 vesicles and mitochondria (Fig. 5) . 183
184

Role of PVAP domains in VAP assembly 185
To identify which parts of the PVAP are required for VAP assembly, truncated mutants lacking 186 the last 10, 20, 30, 40 or 70 C-terminal residues (ΔC10, ΔC20, ΔC30, ΔC40 or ΔC70) were 187 constructed (Fig. 6 ). EM analysis of E.coli cells transfected with these constructs revealed VAPs 188 only in case of the ΔC10 mutant (Fig. 6) . 189
190
By contrast, VAPs did not form after truncation of 20 to 70 C-terminal residues (PVAPΔC20, 191 ΔC30, ΔC40 or ΔC70, Fig. 6 ), corresponding to one to three C-terminal α-helical segments. 192
Instead, expression of these constructs resulted mostly in protein aggregates. In addition, 193 constructs lacking 20-40 C-terminal residues caused the inner membrane of E.coli to form large 194 invaginations, suggesting that these variants still interact with the membrane (Fig 6b) . The effect 195 was most pronounced for PVAPΔC20. In contrast, PVAPΔC70 did not produce any membrane 196 invaginations (Fig 6b) . Supplementary Fig.  210 6). However, there was no evidence of VAPs in these cells (Fig 6b) . 211
Taken together these findings indicate that the N-terminal domain is essential for membrane 212 insertion of PVAP and for the interaction between PVAP protomers, which results in the 213 assembly of a protein sheet on the inner membrane surface. The C-terminal domain of PVAP 214
(except the last 10 residues, which are predicted to be disordered) is required for VAP 215 formation. Without this domain, the protein aggregates instead of forming VAPs. 216
217
PVAP oligomers 218
To characterize the oligomerization of PVAP in vitro, we fused a His-tag to the C-terminus and 219 expressed the protein heterologously in E. coli. Isolated membranes were solubilized with the 220 detergent N-laurylsarcosine. PVAP was purified by nickel affinity chromatography and size 221 exclusion chromatography. The single peak in the gel filtration profile corresponds to a 222 molecular mass of ~70 kDa ( Supplementary Fig. 7 ). SDS-PAGE analysis of peak fractions show 223 discrete PVAP bands at ~10, 20, 30 and 70 kDa ( Supplementary Fig. 7 ), indicating that in 224 detergent solution PVAP forms different oligomers, the largest of which is most likely a 225 heptamer. A PVAP heptamer is also suggested by gel filtration chromatography. 226
227
Discussion 228
The VAP, an archeoviral egress structure that takes the shape of a large sevenfold pyramid in the 229 host membrane, is without parallel in biology. It consists of multiple copies of PVAP, a 10 kDa 230 membrane protein, which forms VAPs in the membrane, evidently without the need for any 231 other cellular component. 232
233
How does the 10 kDa PVAP assemble to form sevenfold pyramids in the membrane? To address 234 this question, we investigated the VAP structure itself by electron cryo-tomography, and have 235 studied the membrane insertion and biochemical properties of PVAP. We have demonstrated 236 that PVAP forms VAPs in archaeal, bacterial and eukaryotic membranes, into which it inserts 237 indiscriminately, and that, with the exception of the last 10 C-terminal residues, the entire length 238 of the protein is required for VAP assembly. Even more remarkably, VAPs were observed in virtually all cellular membranes of the eukaryote 255 S. cerevisiae, including the nuclear envelope, the ER, the mitochondrial outer membrane and the 256 plasma membrane. This demonstrates that, in contrast to other known type of protein 257 spontaneously integrating into membranes, PVAP is able to insert into practically any biological 258 lipid bilayer, solely by virtue of its N-terminal transmembrane segment. Once inserted into the 259 bilayer, it forms sevenfold pyramids, irrespective of fundamental differences in lipid or protein 260 composition of the target membrane. These characteristics render PVAP a unique, universal 261 membrane remodeling tool. 262
263
Supramolecular organisation of VAPs 264
Whole-cell electron cryo-tomography and subtomogram averaging revealed that the VAPs 265 consist of the same two layers of roughly equal thickness in all endogenous and heterologous 266 expression hosts. The outer layer was continuous with the plasma membrane, whereas the inner 267 layer formed a discontinuous sheet at the cytoplasmic membrane surface. As PVAP must insert 268 with its N-terminal TM segment into the plasma membrane, the outer layer most likely consists 269 of multiple copies of this part of PVAP plus interspersed membrane lipid. In turn, the 270 cytoplasmic protein sheet must consist of the tightly associated C-terminal domains of the 271 protein. The low-density region between the two layers would then account for the linker region 272 between the cytoplasmic domains and the N-terminal trans-membrane segments (Fig. 7a) . 273
Recently it was suggested that the opening of STIV-induced VAPs depends on polymerization of 275 ESCRT-III homologs, resulting in the 'stripping' of VAPs from their cytoplasmic membrane (21). 276
Our observation that the outer layer of the double-layered VAP structure is continuous with the 277 plasma membrane (Fig 4) curved in a right-handed fashion (Fig. 4 f) . In the open state, the edges of the seven individual 285 facets are curved in the same way (Fig. 4 f) . In the open VAP, each facet curls outwards (Fig. 4 f) . 286
This suggests that in the closed state, the VAP structure is under mechanical tension. This 287 tension is likely to provide the energy required for VAP opening. As the tip of the VAP displays 288 the point of strongest membrane curvature in the whole assembly, it most likely serves as 289 predetermined breaking point, at which the pyramid would begin to unfold along its seams. 290
291
VAP assembly and opening 292
We propose a model for VAP assembly (Fig. 7) . Upon synthesis in the cytosol, PVAP integrates 293 spontaneously into the cell membrane, depending solely on the hydrophobicity of its N-terminal 294 transmembrane helix segment. In the membrane, tight interactions between PVAP protomers 295 result in the formation of protein sheets, which consist of the observed two layers. We propose 296 that this interaction involves both the N-terminal transmembrane helices and the C-terminal 297 hydrophilic PVAP domains, as indicated by the expression of truncation constructs. 298
299
In order to assemble into a pyramid instead of a flat sheet, at least two different kinds of 300 interactions between PVAPs are necessary, one in-plane interaction within the triangular facets, 301
and one out-of-plane interaction, at the edges of the pyramid. The interaction at the edges is 302 most likely weaker than the in-plane interaction, so that the pyramids open along these lines. 303
Since all VAPs observed in S. islandicus or in heterologous systems grow to roughly the same size, 304 the expansion of VAP must be constrained in some way. 305
At present it is unknown if the pyramids are built in a one-by-one self-assembly process from 307 individual PVAP protomers or if, upon membrane insertion, the protomers assemble into 308 heptamers, which then combine into pyramids in a second stage of assembly. The prior 309 formation of heptamers in the membrane is suggested by the gel filtration experiments, which 310
show one homogenous peak of ~70 kDa in detergent solution. Given that detergent mimics the 311 hydrophobic membrane environment, it is not unlikely that the same interactions that give rise 312 to the heptamer in a detergent micelle would also promote the formation of heptamers in the 313 membrane, which may thus be the building blocks of the pyramids. 314 315 VAP opening presumably involves a host or virus-specific factor, since the pyramids only open in 316 virus-infected Sulfolobus cells but remain closed in PVAP-expressing bacteria and yeast. Once the 317 mechanism that triggers VAP opening is elucidated, this system could be utilised to introduce 318 ~100 nm apertures in any lipid bilayer. VAPs might then be used for targeted drug delivery, 319 releasing compounds from liposomes upon a specific signal. In addition, the PVAP 320 transmembrane domain has the ability to insert into all types of biological membranes and may 321 therefore be fused to proteins that otherwise cannot be reconstituted into lipid bilayers. This 322 system thus has interesting potential applications in basic research, biotechnology and therapy. 323 324
Materials and Methods 326
Virus and host strains S. islandicus LAL 14/1 cells were grown, synchronized and infected with 328 SIRV2 as described previously (7) and in the Supplementary Information (SI). 329
330
Plasmid constructs and transformation of S. acidocaldarius SIRV2_ORF98 (NCBI RefSeq ID: 331 NP_666583) was amplified from SIRV2 genomic DNA and cloned into the pSVA1450 plasmid 332 behind an araS promoter, which yielded pTQ26. pTQ26 was transformed to S. acidocaldarius 333 M31 as described in the SI. western blotting was performed as described in ref (9) and (7). 343
344
Plasmid constructs and transformation of S. cerevisiae SIRV2_ORF98 was amplified from 345 SIRV2 genomic DNA and cloned in the expression vector pCM190. S. cerivisiae was transformed 346 with this plasmid. A pre-culture was grown in selective medium as described in the SI. After one 347 day, cells were diluted 1/1000 in medium without doxycyclin. 348
Immuno-electron microscopy Yeast cells were fixed, washed, pelleted in gelatin and the 350 gelatine pellet was solidifed on ice and cut into small blocks as described in the SI. These were 351 infiltrated 2.3M sucrose, mounted on aluminium pins and frozen in liquid nitrogen. Thin sections 352
were cut and picked up in a 1:1 mixture of 2.3M sucrose and 2% methylcellulose. Labelling for 353 PVAP was done as described previously (7) . 
7-fold rotational symmetry using the PEET software as described in the SI. The resolution of the 375 map was estimated using the ResMap software (13) . 376 377 PVAP purification A codon-optimized SIRV_ORF98 gene was synthetized and inserted in the 378 plasmid pET26b. E. coli BL21DE3/Rosetta/pLysS cells were transformed with this plasmid. 379
Protein expression was induced with 1mM IPTG. After 2 hours, cells were pelleted, resuspended 380 in lysis buffer and disrupted with a Microfluidizer. The membrane fraction was pelleted by 381 centrifugation, and diluted in 50 mM Tris pH 7.0, 300 mM NaCl to a protein concentration of 5 382 mg/ml. 1.5% N-laurylsarcosine was added. After high-speed centrifugation the supernatant was 383 loaded onto a Ni-NTA column followed by several washing steps. The protein was eluted in 384 buffer containing 500 mM imidazole and concentrated using Amicon spin columns with a 30 kDa 385 cutoff prior to loading onto a gel filtration column, as described in more detail in the SI. 
Supplementary Methods
Virus and host strains The SIRV2 virus stock was prepared and the S. islandicus LAL 14/1 strain grown as described previously (1) . For analysis of morphological changes upon viral infection, cells were synchronized by dilution of precultures in fresh medium. The cultures were grown for ~12 hours until an OD of 0.1-0.2 was reached and SIRV2 was added directly to the cultures as described (1) .
Plasmid constructs and transformation of S. acidocaldarius For the expression of PVAP in S.
acidocaldarius M31, SIRV2_ORF98 (NCBI RefSeq ID: NP_666583) was amplified from SIRV2 genomic DNA and cloned into the lacS gene locus in the pMZ1 plasmid (2) using the NcoI and BamHI sites. SIRV2_ORF98 (PVAP) and the araS promoter were transferred from pMZ1 to the pSVA1450 plasmid (3) using the NcoI and EagI sites, which yielded pTQ26. pTQ26 was transformed to S. acidocaldarius M31. The preparation of competent cells, methylation of the plasmid, and electroporation were carried out as described (4) by isolation of membranes as described in ref (11) , followed by SDS PAGE, western blotting and immunolabelling with antibodies raised against PVAP as described (5).
Plasmid constructs and transformation of S. cerevisiae For the overexpression of SIRV2_PVAP (PVAP) in Saccharomyces cerivisiae, SIRV2_PVAP was amplified from SIRV2 genomic DNA and cloned in the expression vector pCM190 (7) using PstI and XbaI sites. S. cerivisiae was transformed with the plasmid according to Gari et al. (7) . After selection on plates without uracil a single colony was picked and grown at 30 °C overnight in a pre-culture in selective uracil-free medium, and with 10 microgram/ml doxycyclin. After one day, cells were diluted 1/1000 in medium without doxycyclin.
Immuno-electron microscopy Yeast cells were fixed with 4% paraformaldehyde in 0.1M Hepes, pH 5.4 for 2 h at RT. The cells were then washed with 50 mM NH4Cl in PBS to quench free aldehyde groups and pelleted in 12% gelatin in PBS. The gelatine pellet was solidifed on ice and cut into small blocks, which were infiltrated over night at 4°C with 2.3M sucrose for cryoprotection, mounted on aluminium pins and frozen in liquid nitrogen. Thin sections were cut with a UC6/FC6 (Leica microsystems, Vienna, Austria) and picked up in a 1:1 mixture of 2.3M sucrose and 2% methylcellulose (8) . Labelling for PVAP was done as described previously (5).
High-pressure freezing and freeze-substitution E.coli cells were taken up in cellulose capillary tubes (Leica Microsystems GmbH, Vienna, Austria) as described in (9) . S. cerevisiae cultures were concentrated by filtration. Tubes or cell concentrates were placed into brass planchettes filled with 1-hexadecen (Agar Scientific, Stansted, United Kingdom). Samples were frozen in a HPM 010 high pressure freezer (Baltec, now Abra Fluid AG, Widnau, Switzerland).
Freeze-substitution was performed in anhydrous acetone containing 2% osmium tetroxide (Merck, Germany). Small cracks were introduced under liquid nitrogen in solid 1-hexadecen by pre-cooled fine point forceps (No 5, Dumont, Switzerland) to allow perfusion of the substitution mix. Freeze-substitution was carried out at -90°C for 24h, and at -60°C and -30°C for 8h each in a freeze substitution device (Leica Microsystems GmbH, Vienna, Austria). Afterwards the temperature was raised to 0°C and the samples were washed with dry acetone and embedded stepwise in EPON. After heat polymerization thin sections were cut with an Ultracut UCT microtome (Leica Microsystems GmbH, Vienna, Austria). Sections were collected on 200 mesh Formvar-coated copper grids and post-stained with 4% uranylacetate and Reynold's lead citrate.
Images were recorded with a JEOL 1010 electron microscope at 80 kV equipped with an Olympus Keen View camera (Olympus Soft imaging systems, Münster, Germany).
Whole cell cryo-tomography S. islandicus cells were harvested shortly after infection, concentrated by low-speed centrifugation (3000 rpm for 10 min) and plunge-frozen directly in the growth medium. For this, cell pellets were resuspended in an equal volume of fresh medium.
E. coli cells overexpressing PVAP were harvested at the same conditions, washed once in 50mM
Tris, 300mM NaCl, pH7 and plunge-frozen in the same buffer. Before freezing, suspensions were mixed with an equal volume of 10 nm colloidal protein-A gold suspension (Aurion, Wageningen, The Netherlands). 3 μl of this mixture were added to a 300 mesh R2/2 glow-discharged Quantifoil grid, blotted and rapidly injected into liquid ethane using a homemade plunge freezer.
Tomograms were recorded with a Polara G2 Tecnai field emission transmission electron microscope (FEI, Hillsboro, USA) operated at 300 kV, equipped with a Gatan Tridiem energy filter and 2x2 k CCD camera (Gatan Inc., Pleasanton, USA). Zero-loss filtered images were collected using the Digital Micrograph software (Gatan Inc., Pleasanton, USA). Tomographic tilt series were recorded with the FEI tomography software (FEI Company, Hillsboro, USA). Tilt series were generally collected in a range of -60° to +60° in steps of 1.5° or 2°, at 6-9 μm defocus and magnifications of 41.000x, 34.000x or 27.500x, corresponding to a pixel size of 0.5766nm, 0.709nm or 1.073nm, respectively. Tomograms were reconstructed using the IMOD software package (10) and de-noised by non-linear anisotropic diffusion (NAD) (11) .
Subtomogram averaging For subtomogram averaging of VAPs, 57 pyramid volumes were cut out from a single tomogram of a PVAP overexpressing E. coli cell, aligned and averaged using the PEET software (12,13) as described before (14) . The average volumes were averaged further by applying 7-fold rotational symmetry. 3D maps obtained by subtomogram averaging were displayed and analyzed in 3Dmod (IMOD,(34)) or UCSF chimera (15) . The resolution of the map was estimated using the ResMap software (16) .
PVAP purification
The codon-optimized gene coding for PVAP was synthetized (Genscript) and inserted in to the expression plasmid pET26b (Novagene) using the restriction sites NdeI and XhoI. E. coli BL21DE3/Rosetta/pLysS cells were transformed with the resulting plasmid and transformants were selected using kanamycin (Kan, 50µg/ml) and chloramphenicol (Cam, 34µg/ml). An overnight pre-culture of a single colony was transferred to 12L "terrific broth" (TB) medium containing Kan and Cam and incubated in the shaker at 160 rpm until the optical density at 600nm (OD600) reached 0.8 -1.0. Protein expression was induced with 1mM IPTG (isopropyl--D-1-thio-galacatopyranoside) at 37°C. After 2 hours, cells were pelleted, resuspended in lysis buffer (50 mM Tris pH 7.0, 300 mM NaCl, 0.5 mM PMSF) and disrupted with a Microfluidizer (M-110L, Microfluidics Corp., Newton, MA). Unbroken cells were removed by 30 min. centrifugation at 14,000g. The membrane fraction was pelleted by centrifugation of the supernatant at 100.000g for 90 min. at 4°C ,resuspended in 50 mM Tris pH 7.0, 300 mM NaCl and diluted to a protein concentration of 5 mg/ml. Membranes were solubilized by adding of Nlaurylsarcosine to a final concentration of 1.5%. Non-solubilized protein was removed by centrifugation for 60 minutes at 100.000g. The supernatant containing the His-tagged protein was loaded onto a Ni-NTA column and unspecifically bound proteins were removed in several washing steps. The protein was eluted in buffer containing 500 mM imidazole and concentrated using Amicon spin columns (Millipore) with a 30 kDa cutoff prior to loading onto a gel filtration column (Superdex75). Purified protein was eluted using 50 mM Tris pH 7.0, 300 mM NaCl and 0.05 % N-laurylsarcosine as running buffer.
